Cargando…
Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with a 5-year survival rate of <8%. Its dismal prognosis stems from inefficient therapeutic modalities owing to the lack of understanding about pancreatic cancer pathogenesis. Considering the molecular complexity and heterogeneity of...
Autores principales: | Khatri, Indu, Ganguly, Koelina, Sharma, Sunandini, Carmicheal, Joseph, Kaur, Sukhwinder, Batra, Surinder K., Bhasin, Manoj K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333820/ https://www.ncbi.nlm.nih.gov/pubmed/30644396 http://dx.doi.org/10.1038/s41598-018-36328-w |
Ejemplares similares
-
Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
por: Jahan, Rahat, et al.
Publicado: (2019) -
Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis
por: Bhatia, Rakesh, et al.
Publicado: (2020) -
A Transcriptomics-Based Meta-Analysis Combined With Machine Learning Identifies a Secretory Biomarker Panel for Diagnosis of Pancreatic Adenocarcinoma
por: Khatri, Indu, et al.
Publicado: (2020) -
The Current Landscape of Antibody-based Therapies in Solid Malignancies
por: Shah, Ashu, et al.
Publicado: (2021) -
Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer
por: Pothuraju, Ramesh, et al.
Publicado: (2020)